Tag: Diabetes: Type II
Vitamin D Does Not Impact Kidney Outcomes in Prediabetes
Secondary analysis of randomized trial shows no difference in progression of KDIGO risk scores with daily vitamin D versus placebo
USPSTF Says Start Diabetes Screen at Age 35 for Those With Overweight, Obesity
Overweight or obese adults should be screened for prediabetes, type 2 diabetes and offered or referred for preventive interventions
2001 to 2017 Saw Increase in Prevalence of T1DM, T2DM in Youth
Relative increase of 45.1 percent reported in prevalence of type 1 diabetes and relative increase of 95.3 percent reported in type 2 diabetes
Long-Term Complications Common With Youth-Onset T2DM
Risk factors for development of complications include minority race or ethnic group, hyperglycemia, hypertension, dyslipidemia
Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
Factors in therapeutic inertia examined in adults newly diagnosed with T2DM receiving primary care in the U.K.
ADA: Peds Hospitalization Rates for New-Onset T2DM Up During Pandemic
Hospitalization rate for new onset diabetes up from 0.27 percent in 2019 to 0.62 percent in 2020; mean admission HbA1c, glucose also higher
ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
ADA: Efpeglenatide Lowers Risk for Adverse CV Events in T2DM
Findings among patients with type 2 diabetes and history of cardiovascular disease or current kidney disease
Sotagliflozin Ups Days Alive, Out of Hospital in T2DM, Heart Failure
Increase in rate of days alive and out of hospital mainly due to drop in rate of days dead for patients with T2DM, worsening heart failure
Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D
Lower exacerbation counts, fewer health care encounters for asthma symptoms seen in asthma patients with T2D initiating GLP-1R agonists
